Form 4: Tenet Healthcare Director Receives Equity Grant

Director Cecil D. Haney was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.

Summary

• Director Cecil D. Haney received a grant of 1,188 restricted stock units (RSUs) on May 27, 2026.
• The RSUs were issued under the company's Stock Incentive Plan.
• Each RSU represents the economic equivalent of one share of Tenet Healthcare common stock.
• The reporting person has the option to receive up to 37% of the grant in cash rather than shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Value of the equity grant is subject to future fluctuations in Tenet Healthcare's common stock price.

Future Outlook

The RSUs vest on May 27, 2027, at which point the director will receive shares or a cash equivalent for up to 37% of the units.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder interests in the healthcare services sector.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for S&P 500 healthcare companies.
• The one-year vesting period is a common retention and alignment mechanism used by peers such as HCA Healthcare and Universal Health Services.

Stakeholder Impact

• Minimal impact on shareholders as the grant represents a standard component of director compensation.

Next Steps

• Vesting of the restricted stock units on May 27, 2027.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Director Compensation, Restricted Stock Units, Insider Transaction